Arcturus Therapeutics Holdings Inc at JPMorgan Healthcare Conference Transcript
Hello. Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is [Edwin Zayne] I'm a member of the JPMorgan Healthcare team. Today, I would like to introduce you to the team from Arcturus Therapeutics. Please join me in welcoming our presenter, Joe Payne, who is the President and CEO of Arcturus.
All right. Thank you. Another year has gone by everyone. It was an exciting one for Arcturus. It's be happy to summarize. Some of the progress we've made this year has been extraordinary, very, very pleased with our team and what we've done. It's exciting to be with you. And we have a lot of friends and colleagues here as well that we work with. So I'm glad we could share this together. Arcturus has a messenger RNA medicines and vaccines company based in San Diego, we have next generation technologies. So don't kid yourself. We are different with respect to our science. We are now global with a late-stage clinical company for sure. We have an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |